Call for Abstract

4th World Congress on Virology, will be organized around the theme “Anti-Viral Immunity and Countermeasures to Control Disease Pathogenesis”

Virology-2014 is comprised of 15 tracks and 93 sessions designed to offer comprehensive sessions that address current issues in Virology-2014.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1General viral science
  • Track 1-2Viral genetics and transmission
  • Track 1-3Genomics and proteomics of viruses
  • Track 1-4Viral replication mechanisms
  • Track 2-1New strategies for anti-viral agents
  • Track 2-2Viral threat breakout prediction and measures
  • Track 2-3Epidemiology of emerging viruses
  • Track 2-4Prevention and measures to curb viral breakouts
  • Track 2-5Viral evolution
  • Track 3-1Human papilloma virus
  • Track 3-2Rabies
  • Track 3-3Rubella
  • Track 3-4Mumps and measles
  • Track 3-5Japanese encephalitis
  • Track 3-6Rotavirus
  • Track 3-7Hand, foot and mouth diseases
  • Track 3-8Combating viral diseases in Afro-Asian continents
  • Track 4-1Systems biology in HIV, METH and cART
  • Track 4-2HIV diagnosis
  • Track 4-3HIV and retroviral transmission and prevention
  • Track 4-4Anti-retroviral therapies and associated complications
  • Track 4-5Psychological and social issues associated with HIV
  • Track 4-6Opportunistic diseases in HIV
  • Track 4-7Immunology of HIV and retroviral infections
  • Track 4-8Clinical trials in HIV AIDS
  • Track 4-9Nucleoside analogues
  • Track 4-10HIV vaccines and advances
  • Track 4-11Molecular mechanisms and novel targets
  • Track 5-1Viral gastroenteritis
  • Track 5-2Hepatocellular carcinomas
  • Track 5-3HPV associated cervical cancers
  • Track 5-4Human herpes virus and cancers
  • Track 5-5Simian virus 40
  • Track 5-6Other cancer associated viral infections
  • Track 6-1Influenza A (H1N1)
  • Track 6-2Severe acute respiratory syndrome
  • Track 6-3Avian flu (H5N1)
  • Track 6-4Dengue virus
  • Track 6-5Hanta virus
  • Track 6-6Ebola virus
  • Track 6-7West nile virus
  • Track 7-1DNA vaccines
  • Track 7-2Interleukin immune therapy
  • Track 7-3Antibody therapy against viruses
  • Track 7-4Gene therapy for viral infections
  • Track 7-5Viral vaccines
  • Track 7-6Vaccine allergy
  • Track 7-7Antiviral drugs and adjuvants
  • Track 7-8Safety evaluation of viral vaccines
  • Track 7-9Antigen presenting cell-targeted therapy
  • Track 8-1Hepatitis A
  • Track 8-2Hepatitis B
  • Track 8-3Hepatitis C
  • Track 8-4Hepatitis D
  • Track 8-5Hepatitis E
  • Track 8-6Epidemiology hepatitis
  • Track 8-7Hepatitis virology and immunology
  • Track 9-1Viral immune evasion
  • Track 9-2Receptors and signalling
  • Track 9-3Neutralizing antibodies
  • Track 9-4Adjuvants and cell-based immunity
  • Track 9-5Prophylactic and therapeutic vaccines
  • Track 10-1Neurological disorders by viruses
  • Track 10-2Molecular diagnosis of nervous system viruses
  • Track 10-3Neuropathogenesis
  • Track 10-4AIDS associated neural diseases
  • Track 11-1Plant virus epidemiology, ecology and evolution
  • Track 11-2Viral vector biology and transmission
  • Track 11-3Wheat and rice viruses
  • Track 11-4Vegetable viruses
  • Track 11-5Tobacco virus
  • Track 11-6Grape vine leaf roll viral disease
  • Track 11-7Virus resistant plants and disease control
  • Track 11-8Biotechnology in plant viral diseases
  • Track 11-9Viral mediated plant transformations
  • Track 12-1Zoonotic, vector-borne and emerging diseases of veterinary importance
  • Track 12-2Viroid and prion diseases
  • Track 12-3Functional genomics and proteomics of animal viruses
  • Track 12-4Animal vaccines and viral immunology
  • Track 13-1Impact on bacterial genome evolution
  • Track 13-2Phage therapy and its applications
  • Track 13-3Clinical trials in phage therapy
  • Track 13-4Novel anti-phage mechanisms in bacteria
  • Track 14-1Bioinformatics in drug discovery
  • Track 14-2Drug-Drug interactions
  • Track 14-3Lead targets in drug discovery
  • Track 14-4Antiviral drug resistance
  • Track 14-5Virus-Drug interactions
  • Track 15-1Stem cell therapy for viral infections: Promises and challenges
  • Track 15-2New strategies to combat flu viruses
  • Track 15-3Strain identification assays and rapid diagnostic testing for viral infections
  • Track 15-4Clinical virology
  • Track 15-5Viruses and nanotechnology